Episode-3

Dr. Arwa Farag is an Assistant Professor at the Division of Oral Medicine, Department of Oral Diagnostic Sciences at King AbdulAziz University, Jeddah, Saudi Arabia and a Visiting Professor at the Department of Diagnostic Sciences, Tufts University School of Dental Medicine (TUSDM). Dr. Farag graduated from King Saud University College of Dentistry, Riyadh, Saudi Arabia. She completed her residency training in oral medicine at the Brigham and Women Hospital/Dana Farber Cancer Institute, Boston, MA and earned her Doctorate of Medical Science Degree (DMSc) from Harvard School of Dental Medicine. She also completed her fellowship in TMD/Orofacial pain at TUSDM. Dr. Farag is a Diplomat of the American Board of Oral Medicine and a Diplomat of the American Board of Orofacial Pain. She is also a Fellow of The Royal College of Surgeon of Edinburgh. Dr. Farag is an active member and a frequently invited speaker of the American Academy of Oral Medicine, the European Association of Oral Medicine, the American Academy of Orofacial Pain, the American Association of Dental Research, and the International Association of Dental Research. She is currently serving as a chair for the scientific committee of the American Academy of Oral Medicine as well as a Steering member of the World Workshop on Oral Medicine. Dr. Farag continues to support scholars with many publications in reputable journals. Furthermore, she is currently a reviewer for the Journal of the American Dental Association,Journal of Oral Rehabilitation, Oral Diseases, and BMJ. Dr. Farag has a clinical interest in early detection of oral cancer, management of oral manifestation of systemic disease, management of oral complication of cancer therapy, and treatment of complicated chronic orofacial pain conditions. Her area of research focuses on elucidating the immunologic etiologies as well as the development of diagnostic modalities for Sjogren syndrome. In addition, she is currently involved in several multicenter investigations in the USA and Europe aiming to develop standardized diagnostic criteria and treatment outcome measures for oral mucosal lesions as well as neuropathic pain conditions affecting the head and neck area.